Stora Enso has acquired all shares of US biotechnology company Virdia. The transaction value is put at $33m (€24m) in addition to potential incentive payouts of around $29m (€21m) if Vidria meets technical and commercial milestones by 2017. “The acquisition of Vidria supports Stora Enso’s biomaterials division ...
Read more
You can only use this article with a valid subscription and registration. Registered subscribers can access all articles after entering their user name and password.
- Ad -